Condition

Endocrine System Diseases (3)

Growth Hormone Deficiency, Pediatric (3)

Pituitary Diseases (3)

Hormone Deficiency (2)

Hormones (1)

hGH (Human Growth Hormone) (1)

Overall Status

Completed (2)

Active, not recruiting (1)

Sign in for free

Phase

phase 3 (3)

Sponsor

Ascendis Pharma Endocrinology Division A/S (2)

Ascendis Pharma A/S (1)

Collaborator

Intervention

transcon hgh (2)

once daily subcutaneous injection of genotropin (1)

once weekly subcutaneous injection of transcon hgh (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

growth hormone deficiency, pediatric

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (TransCon hGH)

Completed

Growth Hormone Deficiency, Pediatric
+3 more

TransCon hGH

Birmingham, Alabama
+23 more

Dec 7, 2021

Growth Hormone Deficiency, Pediatric, hGH (Human Growth Hormone), Endocrine System Diseases Trial in Worldwide (Once weekly

Completed

Growth Hormone Deficiency, Pediatric
+4 more

Once weekly subcutaneous injection of TransCon hGH
Once daily subcutaneous injection of Genotropin

Birmingham, Alabama
+52 more

Dec 6, 2021

Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (TransCon hGH)

Active, not recruiting

Growth Hormone Deficiency, Pediatric
+3 more

TransCon hGH

Birmingham, Alabama
+41 more

Oct 13, 2021